Search Results

Centauri Therapeutics Limited, an immunotherapy company focused on the treatment of infectious diseases, announced three senior appointments: Dr Jennifer Schneider as Chief Executive Officer, Dr Helen Bright as Vice President of Research & Development, and Professor David Roblin FRCP FMedSci as Chair of the Board of Directors.

Galaxy Medical announced that it received the CE Mark for its CENTAURI Pulsed Electric Field System and launched its commercial program.

Centauri Therapeutics Limited, an immunotherapy company founded by Animatrix Founders LLP and focused on the treatment of infectious diseases, announced the close of its £24 million GBP Series A investment round.

We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrythmias, announced the acquisition of Galvanize Therapeutics’ Electrophysiology Technology division.

Centauri Therapeutics, an immunotherapy company active in oncology and infectious diseases, announces that it will attend the following scientific and investor conferences

The agency’s warning letter outlines Applied Therapeutics’ failure to provide adequate information regarding the clinical trial—including a dosing error for govorestat—claims that the company said it had already addressed.

After extending its review period to evaluate additional submissions, the FDA ultimately denied Applied Therapeutics’ govorestat for galactosemia, citing “deficiencies” with the application. The biotech plans to meet with the regulator to discuss the best way forward for the drug.